A detailed history of Ep Wealth Advisors, LLC transactions in Xencor Inc stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 13,000 shares of XNCR stock, worth $260,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Previous 13,000 -0.0%
Holding current value
$260,390
Previous $246,000 6.1%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 22, 2023

SELL
$20.08 - $25.39 $535,352 - $676,922
-26,661 Reduced 67.22%
13,000 $261,000
Q2 2023

Aug 14, 2023

SELL
$24.77 - $29.9 $1.12 Million - $1.35 Million
-45,188 Reduced 53.26%
39,661 $990,000
Q1 2023

Jun 05, 2023

BUY
$25.95 - $36.95 $1.86 Million - $2.65 Million
71,849 Added 552.68%
84,849 $2.37 Million
Q4 2022

Jun 12, 2023

SELL
$24.79 - $30.86 $1.78 Million - $2.22 Million
-71,849 Reduced 84.68%
13,000 $338,000
Q3 2022

Dec 02, 2022

SELL
$24.62 - $32.44 $13,614 - $17,939
-553 Reduced 4.08%
13,000 $338,000
Q2 2022

Aug 11, 2022

BUY
$19.74 - $29.01 $9,139 - $13,431
463 Added 3.54%
13,553 $371,000
Q1 2022

May 20, 2022

SELL
$26.68 - $41.63 $3,068 - $4,787
-115 Reduced 0.87%
13,090 $349,000
Q3 2021

Nov 23, 2021

BUY
$30.65 - $35.68 $194,658 - $226,603
6,351 Added 92.66%
13,205 $431,000
Q3 2021

Nov 16, 2021

SELL
$30.65 - $35.68 $188,558 - $219,503
-6,152 Reduced 47.3%
6,854 $431,000
Q2 2021

Aug 24, 2021

SELL
$34.33 - $44.68 $4,806 - $6,255
-140 Reduced 1.06%
13,006 $449,000
Q4 2020

Feb 18, 2021

SELL
$36.63 - $47.63 $251,062 - $326,456
-6,854 Reduced 34.27%
13,146 $574,000
Q3 2020

Nov 17, 2020

BUY
$30.09 - $43.02 $601,800 - $860,400
20,000 New
20,000 $776,000
Q2 2020

Aug 14, 2020

SELL
$27.76 - $33.42 $759,319 - $914,137
-27,353 Closed
0 $886,000
Q4 2019

Feb 14, 2020

SELL
$32.75 - $41.43 $163,750 - $207,150
-5,000 Reduced 15.45%
27,353 $941,000
Q3 2019

Nov 18, 2019

BUY
$33.73 - $46.27 $1.09 Million - $1.5 Million
32,353 New
32,353 $1.09 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.2B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Ep Wealth Advisors, LLC Portfolio

Follow Ep Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.